Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Inmune Bio Inc (INMB)
NASDAQ:INMB
Inmune Bio (INMB) Stock Price & Analysis
265 Followers
INMB Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$6.50 - $14.74
Previous Close$10.34
Volume76.66K
Average Volume (3M)81.54K
Market Cap
$186.39M
Enterprise Value$160.98M
Total Cash (Recent Filing)$35.85M
Total Debt (Recent Filing)$10.44M
Price to Earnings (P/E)-6.2
Beta0.88
Next Earnings
May 01, 2024EPS Estimate
-$0.53Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.67
Shares Outstanding18,026,473
10 Day Avg. Volume102,047
30 Day Avg. Volume81,538
Standard Deviation0.28
R-Squared0.15
Alpha0.01
Financial Highlights & Ratios
Price to Book (P/B)8.95
Price to Sales (P/S)1202.54
Price to Cash Flow (P/CF)-13.70
P/FCF Ratio0.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.04K
Enterprise Value/Gross Profit1.04K
Enterprise Value/Ebitda-10.18
Forecast
1Y Price Target
$19.67Price Target Upside90.23% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Inmune Bio News
Ownership Overview
39.94% Insiders
3.78% Mutual Funds
5.84% Other Institutional Investors
50.44% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
INMB FAQ
What was Inmune Bio Inc’s price range in the past 12 months?
Inmune Bio Inc lowest stock price was $6.50 and its highest was $14.74 in the past 12 months.
What is Inmune Bio Inc’s market cap?
Currently, no data Available
When is Inmune Bio Inc’s upcoming earnings report date?
Inmune Bio Inc’s upcoming earnings report date is May 01, 2024 which is in 13 days.
How were Inmune Bio Inc’s earnings last quarter?
Inmune Bio Inc released its earnings results on Mar 28, 2024. The company reported -$0.47 earnings per share for the quarter, missing the consensus estimate of -$0.427 by -$0.043.
Is Inmune Bio Inc overvalued?
According to Wall Street analysts Inmune Bio Inc’s price is currently Undervalued.
Does Inmune Bio Inc pay dividends?
Inmune Bio Inc does not currently pay dividends.
What is Inmune Bio Inc’s EPS estimate?
Inmune Bio Inc’s EPS estimate is -$0.53.
How many shares outstanding does Inmune Bio Inc have?
Inmune Bio Inc has 18,026,472 shares outstanding.
What happened to Inmune Bio Inc’s price movement after its last earnings report?
Inmune Bio Inc reported an EPS of -$0.47 in its last earnings report, missing expectations of -$0.427. Following the earnings report the stock price went down -1.957%.
Which hedge fund is a major shareholder of Inmune Bio Inc?
Currently, no hedge funds are holding shares in INMB
---
Inmune Bio Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$19.67 (90.23% Upside)
$19.67 (90.23% Upside)
Blogger Sentiment
Bearish
INMB Sentiment 100%
Sector Average 72%
Sector Average 72%
Crowd Wisdom
Neutral
Last 7 Days ▼ 1.9%
Last 30 Days ▲ 1.7%
Last 30 Days ▲ 1.7%
Technicals
SMA
Positive
20 days / 200 days
Momentum
59.07%
12-Months-Change
Fundamentals
Return on Equity
-61.09%
Trailing 12-Months
Asset Growth
-30.31%
Trailing 12-Months
Company Description
Inmune Bio Inc
Inmune Bio, Inc. is a clinical stage biotechnology company, which develops immunotherapies that reprogram a patient's innate immune system to allow the immune system to fight cancer. Its products include INKMUNE and INB03. The company was founded by Mark Lowdell in September 2015 and is headquartered in La Jolla, CA.
---
INMB Earnings Call
Q4 2024
0:00 / 0:00
---
INMB Stock 12 Months Forecast
Average Price Target
$19.67
▲(90.23% Upside)
Technical Analysis
Best Analysts Covering INMB
1 Year
1 Year Success Rate
10/15 ratings generated profit
1 Year Average Return
+13.63%
reiterated a buy rating 18 days ago
Copying Jason McCarthy's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +13.63% per trade.
---